- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/49 - Cinchonan derivatives, e.g. quinine
Patent holdings for IPC class A61K 31/49
Total number of patents in this class: 142
10-year publication summary
|
7
|
11
|
14
|
14
|
13
|
12
|
12
|
10
|
11
|
9
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Avanir Pharmaceuticals, Inc. | 30 |
10 |
| The Regents of the University of California | 20289 |
6 |
| Concert Pharmaceuticals, Inc. | 246 |
6 |
| Beijing Showby Pharmaceutical Co., Ltd. | 15 |
4 |
| Commissariat à l'énergie atomique et aux energies alternatives | 10954 |
3 |
| Mindlab LLC | 5 |
3 |
| Mutual Pharmaceutical Company, Inc. | 21 |
3 |
| Immunologik GmbH | 12 |
3 |
| Glaxosmithkline Intellectual Property Development Limited | 779 |
2 |
| The Trustees of the University of Pennsylvania | 4384 |
2 |
| Arena Pharmaceuticals, Inc. | 359 |
2 |
| General Mills, Inc. | 999 |
2 |
| Indiana University Research and Technology Corporation | 797 |
2 |
| MetrioPharm AG | 49 |
2 |
| Neurocrine Biosciences, Inc. | 427 |
2 |
| NeuroDerm, Ltd. | 140 |
2 |
| New York Blood Center, Inc. | 167 |
2 |
| Orion Corporation | 694 |
2 |
| Pharma Mar, S.A. | 214 |
2 |
| Sumitomo Dainippon Pharma Co., Ltd. | 211 |
2 |
| Other owners | 80 |